260 related articles for article (PubMed ID: 12192735)
1. Toxic oil syndrome: the perspective after 20 years.
Posada de la Paz M; Philen RM; Borda AI
Epidemiol Rev; 2001; 23(2):231-47. PubMed ID: 12192735
[TBL] [Abstract][Full Text] [Related]
2. Toxicologists versus toxicological disasters: toxic oil syndrome, clinical aspects.
Gómez de la Cámara A; Abaitua Borda I; Posada de la Paz M
Arch Toxicol Suppl; 1997; 19():31-40. PubMed ID: 9079192
[No Abstract] [Full Text] [Related]
3. Epidemiology of the toxic oil syndrome.
Philen RM; Posada de la Paz M; Hill RH; Schurz HH; Abaitua Borda I; Gómez de la Cámara A; Kilbourne EM
Arch Toxicol Suppl; 1997; 19():41-52. PubMed ID: 9079193
[No Abstract] [Full Text] [Related]
4. Toxic oil syndrome: a current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome.
Kilbourne EM; Posada de la Paz M; Abaitua Borda I; Diez Ruiz-Navarro M; Philen RM; Falk H
J Am Coll Cardiol; 1991 Sep; 18(3):711-7. PubMed ID: 1869734
[TBL] [Abstract][Full Text] [Related]
5. Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
Kilbourne EM; Bernert JT; Posada de la Paz M; Hill RH; Abaitua Borda I; Kilbourne BW; Zack MM
Am J Epidemiol; 1988 Jun; 127(6):1210-27. PubMed ID: 3369420
[TBL] [Abstract][Full Text] [Related]
6. Immunological aspects of the toxic oil syndrome.
Lahoz C; del Pozo V; Gallardo S; Cárdaba B; Jurado A; Cortegano I; del Amo A; Arrieta I; Palomino P
Arch Toxicol Suppl; 1997; 19():65-73. PubMed ID: 9079195
[No Abstract] [Full Text] [Related]
7. Factors associated with pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
Posada de la Paz M; Philen RM; Abaitua Borda I; Diez Ruiz-Navarro M; Abraira Santos V; Pozo Rodríguez F; Pla Mestre R; Pollán Santamaría M; Sicilia Socias JM; Azpeitia Gamazo P
Epidemiology; 1994 Jul; 5(4):404-9. PubMed ID: 7918809
[TBL] [Abstract][Full Text] [Related]
8. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
Bolster MB; Silver RM
Curr Opin Rheumatol; 1994 Nov; 6(6):642-9. PubMed ID: 7865387
[TBL] [Abstract][Full Text] [Related]
9. Toxic oil syndrome: traceback of the toxic oil and evidence for a point source epidemic.
Posada de la Paz M; Philen RM; Borda IA; Sicilia Socias JM; Gómez de la Cámara A; Kilbourne EM
Food Chem Toxicol; 1996 Mar; 34(3):251-7. PubMed ID: 8621106
[TBL] [Abstract][Full Text] [Related]
10. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
Silver RM
Curr Opin Rheumatol; 1993 Nov; 5(6):802-8. PubMed ID: 8117543
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome.
Mayeno AN; Benson LM; Naylor S; Colberg-Beers M; Puchalski JT; Gleich GJ
Chem Res Toxicol; 1995; 8(7):911-6. PubMed ID: 8555405
[TBL] [Abstract][Full Text] [Related]
12. The toxic oil syndrome: a perspective on immunotoxicological mechanisms.
Yoshida SH; German JB; Fletcher MP; Gershwin ME
Regul Toxicol Pharmacol; 1994 Feb; 19(1):60-79. PubMed ID: 8159816
[TBL] [Abstract][Full Text] [Related]
13. Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8-10, 1991, World Health Organization meeting report.
Philen RM; Posada M
Semin Arthritis Rheum; 1993 Oct; 23(2):104-24. PubMed ID: 8266108
[TBL] [Abstract][Full Text] [Related]
14. Manufacturing processes at two French rapeseed oil companies: possible relationships to toxic oil syndrome in Spain.
Posada de la Paz M; Philen RM; Abaitua Borda I; Bernert JT; Gancedo JC; DuClos PJ; Kilbourne EM
Food Chem Toxicol; 1991 Dec; 29(12):797-803. PubMed ID: 1765323
[TBL] [Abstract][Full Text] [Related]
15. The toxic oil syndrome (TOS, 1981): from the disease towards a toxicological understanding of its chemical aetiology and mechanism.
Aldridge WN
Toxicol Lett; 1992 Dec; 64-65 Spec No():59-70. PubMed ID: 1471212
[TBL] [Abstract][Full Text] [Related]
16. [Eosinophilia myalgia syndrome (EMS) caused by L-tryptophan product and toxic oil syndrome (TOS) caused by denatured rape-seed oil].
Maitani T; Saitoh H
Shokuhin Eiseigaku Zasshi; 2009 Dec; 50(6):279-91. PubMed ID: 20065617
[No Abstract] [Full Text] [Related]
17. Toxic-oil syndrome: case reports associated with the ITH oil refinery in Sevilla.
Posada M; Castro M; Kilbourne EM; Diaz de Rojas F; Abaitua I; Tabuenca JM; Vioque A
Food Chem Toxicol; 1987 Jan; 25(1):87-90. PubMed ID: 3817664
[TBL] [Abstract][Full Text] [Related]
18. Chemical-induced autoimmune reactions and Spanish toxic oil syndrome. Focus on hydantoins and related compounds.
Kammüller ME; Bloksma N; Seinen W
J Toxicol Clin Toxicol; 1988; 26(3-4):157-74. PubMed ID: 3047417
[TBL] [Abstract][Full Text] [Related]
19. Epidemiologic evidence for a new class of compounds associated with toxic oil syndrome.
Posada de la Paz M; Philen RM; Schurz H; Hill RH; Giménez Ribota O; Gómez de la Camara A; Kilbourne EM; Abaitua I
Epidemiology; 1999 Mar; 10(2):130-4. PubMed ID: 10069247
[TBL] [Abstract][Full Text] [Related]
20. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
Silver RM
Curr Opin Rheumatol; 1992 Dec; 4(6):851-6. PubMed ID: 1457280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
